de la Luna et al., 1999 - Google Patents
Integration of a growth‐suppressing BTB/POZ domain protein with the DP component of the E2F transcription factorde la Luna et al., 1999
View HTML- Document ID
- 9243950253983111600
- Author
- de la Luna S
- Allen K
- Mason S
- La Thangue N
- Publication year
- Publication venue
- The EMBO journal
External Links
Snippet
Transcription factor E2F plays an important role in orchestrating early cell cycle progression through its ability to co‐ordinate and integrate the cell cycle with the transcription apparatus. Physiological E2F arises when members of two distinct families of proteins interact as E2F …
- 102000008836 BTB/POZ domains 0 title description 46
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4736—Retinoblastoma protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1079—Screening libraries by altering the phenotype or phenotypic trait of the host
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
Similar Documents
Publication | Publication Date | Title |
---|---|---|
de la Luna et al. | Integration of a growth‐suppressing BTB/POZ domain protein with the DP component of the E2F transcription factor | |
Chen et al. | A functional interaction between the histone deacetylase Rpd3 and the corepressor groucho in Drosophila development | |
Aster et al. | Oncogenic forms of NOTCH1 lacking either the primary binding site for RBP-Jκ or nuclear localization sequences retain the ability to associate with RBP-Jκ and activate transcription | |
Sakamuro et al. | The polyproline region of p53 is required to activate apoptosis but not growth arrest | |
Bauer et al. | Pontin52 and Reptin52 function as antagonistic regulators of β‐catenin signalling activity | |
Yoneda‐Kato et al. | Myeloid leukemia factor 1 regulates p53 by suppressing COP1 via COP9 signalosome subunit 3 | |
Li et al. | Photoreceptor cell differentiation requires regulated proteolysis of the transcriptional repressor Tramtrack | |
Gostissa et al. | Activation of p53 by conjugation to the ubiquitin‐like protein SUMO‐1 | |
Klymenko et al. | A Polycomb group protein complex with sequence-specific DNA-binding and selective methyl-lysine-binding activities | |
Li et al. | Activity regulation of a Hox protein and a role for the homeodomain in inhibiting transcriptional activation | |
Koliou et al. | Nuclear import mechanism of neurofibromin for localization on the spindle and function in chromosome congression | |
Tsang et al. | SCAPER, a novel cyclin A–interacting protein that regulates cell cycle progression | |
Brumby et al. | Drosophila cyclin E interacts with components of the Brahma complex | |
Kobayashi et al. | Engrailed cooperates with extradenticle and homothorax to repress target genes in Drosophila | |
Węsierska‐Gądek et al. | Phosphorylation regulates the interaction and complex formation between wt p53 protein and PARP‐1 | |
US5763219A (en) | Cyclin E variants and use thereof | |
Novy et al. | EAPP, a novel E2F binding protein that modulates E2F-dependent transcription | |
US5876972A (en) | Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation | |
Tang et al. | Bombyx mori cyclin‐dependent kinase inhibitor is involved in regulation of the silkworm cell cycle | |
Mahajan et al. | Molecular cloning of Drosophila HCF reveals proteolytic processing and self‐association of the encoded protein | |
Jackson et al. | p53-dependent activation of the mouse MCK gene promoter: identification of a novel p53-responsive sequence and evidence for cooperation between distinct p53 binding sites | |
Almeida | Modulation of an essential histone methyltransferase in mouse embryonic stem cells | |
Mahadevaraju | X-Signal amplification by Runt mediated antagonism of Groucho in Drosophila | |
Gustincich | Positive and Negative Pathways in Cell Proliferation Control | |
Meloni | The mechanisms of RB/P130-mediated transcriptional repression |